Lakeside Holding (LSH) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Special Meeting scheduled for 2025 to consider major amendments to articles of incorporation and bylaws, new treasury strategy, and equity plan.
Board recommends approval of all proposals, including increasing authorized shares, authorizing preferred stock, and adopting a new equity incentive plan.
Forward-looking statements highlight plans for growth, product development, and financial strategy.
Voting matters and shareholder proposals
Proposals include increasing authorized common stock to 2,000,000,000 shares and authorizing 1,000,000,000 shares of blank check preferred stock.
Amendments to voting thresholds and quorum requirements aim to streamline governance and facilitate future actions.
Adoption of a new treasury reserve strategy focused on Bitcoin and Ethereum, with a cap of 5% of each asset's market cap.
Approval sought for future non-public issuance of up to 100 million shares or $100 million in securities, and a new 2025 Equity Incentive Plan.
Adjournment proposal allows for additional proxy solicitation if needed.
Board of directors and corporate governance
Board unanimously supports all proposals and retains discretion to abandon amendments if deemed not in the best interest of shareholders.
Proposed reduction of quorum requirement from majority to one-third of outstanding shares to facilitate meetings.
Board composition includes a majority of independent directors.
Latest events from Lakeside Holding
- Quarterly revenue surged 95% with new pharma sales, but net loss and credit risk remain concerns.LSH
H1 202619 Feb 2026 - Board seeks approval for director elections, capital structure changes, and a key subsidiary sale.LSH
Proxy Filing30 Jan 2026 - Shareholders are asked to approve director elections, capital structure changes, and a key subsidiary sale.LSH
Proxy Filing23 Jan 2026 - Proxy seeks approval for director elections, capital structure changes, and subsidiary sale.LSH
Proxy Filing12 Jan 2026 - Shareholders will elect five directors, with strong board independence and oversight.LSH
Proxy Filing2 Dec 2025 - IPO offers 1,250,000 shares plus over-allotment, led by Benchmark and Axiom, Nasdaq listing planned.LSH
Registration Filing30 Nov 2025 - Amendment updates IPO exhibits, outlines $1.4M expenses, and details management and indemnification.LSH
Registration Filing30 Nov 2025 - Offering up to 7.97M shares via convertible notes and warrants, with strong Asia-U.S. logistics focus.LSH
Registration Filing29 Nov 2025 - Registering 7.97M shares for resale, the company faces growth, risk, and compliance challenges.LSH
Registration Filing29 Nov 2025